Nick Goeden

About

Nick Goeden, Ph.D., is the co-founder and Chief Technology Officer of Capsida Biotherapeutics, a gene therapy company he co-founded after postdoctoral work at Caltech. His work centers on adeno-associated virus engineering and targeted, non-invasive gene therapies for CNS and ophthalmology disorders. He is also active in the Southern California biotech ecosystem, including service on the Biotech Connection LA advisory board.

Areas of interest